Log In
BCIQ
Print this Print this
 

ACN-1052

  Manage Alerts
Collapse Summary General Information
Company Acorn Biomedical Inc.
DescriptionOral adenosine A3 receptor (ADORA3) antagonist
Molecular Target Adenosine A3 receptor (ADORA3)
Mechanism of ActionAdenosine A3 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today